FCGR1A
High affinity immunoglobulin gamma Fc receptor I
You are using an outdated browser. Please upgrade your browser to improve your experience.
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
virus perturbation | 0.99 | ||
cellular component | 0.88 | ||
drug | 0.85 | ||
biological term | 0.79 | ||
protein domain | 0.73 | ||
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
- OR - satisfy the following criterion:
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Target has at least one approved drug - AND - satisfies the preceding conditions
Click on a row in the table to change the structure displayed.
Data Source | Name | Explore in Pharos | Explore in Source | ||
---|---|---|---|---|---|
Reactome | Adaptive Immune System | ||||
Reactome | Antigen processing-Cross presentation | ||||
Reactome | Class I MHC mediated antigen processing & presentation | ||||
Reactome | Cross-presentation of soluble exogenous antigens (endosomes) | ||||
Reactome | Cytokine Signaling in Immune system | ||||
Name | Explore in Pharos | Explore in Source | ||
---|---|---|---|---|
Adaptive Immune System | ||||
Antigen processing-Cross presentation | ||||
Class I MHC mediated antigen processing & presentation | ||||
Cross-presentation of soluble exogenous antigens (endosomes) | ||||
Cytokine Signaling in Immune system | ||||
GO Term | Evidence | Assigned by | ||
---|---|---|---|---|
Inferred from Electronic Annotation (IEA) | UniProtKB-KW | |||
GWAS Trait | EFO ID | Study Count | SNP Count | Beta Count | Odds Ratio | Evidence (Mean Rank Score) | Provenance | ||
---|---|---|---|---|---|---|---|---|---|
high density lipoprotein cholesterol measurement | 2 | 2 | 2 | 57.2 | |||||
triglyceride measurement | 3 | 2 | 3 | 54.1 | |||||
heel bone mineral density | 1 | 1 | 1 | 42.3 | |||||
apolipoprotein A 1 measurement | 2 | 2 | 2 | 38.1 | |||||
BMI-adjusted hip circumference | 1 | 1 | 1 | 15.8 | |||||
GWAS Trait | EFO ID | Beta Count | Odds Ratio | Evidence (Mean Rank Score) | Provenance | ||
---|---|---|---|---|---|---|---|
high density lipoprotein cholesterol measurement | 2 | 57.2 | |||||
triglyceride measurement | 3 | 54.1 | |||||
heel bone mineral density | 1 | 42.3 | |||||
apolipoprotein A 1 measurement | 2 | 38.1 | |||||
BMI-adjusted hip circumference | 1 | 15.8 | |||||
Species | Name | Source ID | Gene ID | OMA | EggNOG | Inparanoid | ||
---|---|---|---|---|---|---|---|---|
Mouse | MGI:95498 | 14129 | ||||||
Dog | Fc fragment of IgG, high affinity Ia, receptor (CD64) | 403462 | ||||||
Cow | Fc fragment of IgG, high affinity Ia, receptor (CD64) | 282227 | ||||||
Pig | Fc fragment of IgG, high affinity Ia, receptor (CD64) | 613130 | ||||||
Species | Name | OMA | EggNOG | Inparanoid | ||
---|---|---|---|---|---|---|
Mouse | ||||||
Dog | Fc fragment of IgG, high affinity Ia, receptor (CD64) | |||||
Cow | Fc fragment of IgG, high affinity Ia, receptor (CD64) | |||||
Pig | Fc fragment of IgG, high affinity Ia, receptor (CD64) | |||||
PMID | Year | Title |
---|